Commentary: The pros and cons of essential medicines for rich countries

被引：3
|
作者：
Reidenberg, MM
Walley, T
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GF, Merseyside, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 329卷 / 7475期
关键词：
D O I：
10.1136/bmj.329.7475.1172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1172 / 1172
页数：1
相关论文
共 50 条
  • [1] THE PROS AND CONS OF GENERIC MEDICINES
    CAMPBELL, M
    BATEMAN, DN
    LEE, A
    SMITH, JM
    BEANEY, A
    PHARMACOECONOMICS, 1995, 8 (04) : 362 - 363
  • [2] THE PROS AND CONS OF GENERIC MEDICINES - REPLY
    WALKER, R
    PHARMACOECONOMICS, 1995, 8 (04) : 363 - 364
  • [3] The concept of essential medicines: lessons for rich countries
    Hogerzeil, HV
    BRITISH MEDICAL JOURNAL, 2004, 329 (7475): : 1169 - 1172
  • [4] Understand the pros and cons of outsourcing to developing countries
    Kuwahara, Steven S.
    BIOPHARM INTERNATIONAL, 2007, 20 (02) : 30 - 32
  • [5] Potential use of NOACs in developing countries: pros and cons
    Durga Bista
    Leanne Chalmers
    Luke Bereznicki
    Gregory Peterson
    European Journal of Clinical Pharmacology, 2014, 70 : 817 - 828
  • [6] The Pros and Cons of the PROs
    Thoma, Achilleas
    Eaves, Felmont F., III
    AESTHETIC SURGERY JOURNAL, 2018, 38 (03) : 343 - 345
  • [7] Potential use of NOACs in developing countries: pros and cons
    Bista, Durga
    Chalmers, Leanne
    Bereznicki, Luke
    Peterson, Gregory
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (07) : 817 - 828
  • [8] THE IMPLEMENTATION OF ESSENTIAL MEDICINE POLICY IN CHINA: PROS AND CONS
    Hu, S.
    Zhang, Y.
    He, J. J.
    VALUE IN HEALTH, 2012, 15 (07) : A611 - A612
  • [9] The pros and cons of traditional Chinese medicines in the treatment of COVID-19
    Wang, Yali
    Zeng, Xian
    Zhao, Yufen
    Chen, Weiping
    Chen, Yu Zong
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [10] The pros and cons of lymphadenectomy in papillary and follicular thyroid carcinomas - Commentary
    Walgenbach, S
    ZENTRALBLATT FUR CHIRURGIE, 2000, 125 (10): : 840 - 841
12345